Delivery Order SPE2DB20D1100-SPE2DB25FC2U9

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $38,483.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablet, a HIV medication. The contract is a firm-fixed price delivery order with an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award, valued at $18,060.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,696.76, is for the delivery of Biktarvy 50-200-25 mg tablets, which are used to treat HIV. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award for $29,712.57 was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication used to treat HIV infection. The contract has an ultimate completion date of March 11, 2024. The contract was awarded on March 8, 2024 and is a firm fixed-price delivery order. No set-aside was used for this award. AmerisourceBergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $12,500.73 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a brand name HIV medication, to support military treatment programs and facilities. The award is associated with a single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a...
This federal contract award, valued at $19,773.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication Biktarvy, a treatment for human immunodeficiency virus (HIV). The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $44,018.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication used in the treatment of HIV. The contract is a Firm Fixed Price Delivery Order that runs through July 17, 2024. It is not associated with any set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,885.65 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract is a firm fixed-price delivery order with a completion date of December 29, 2022. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC2U9
    Delivery Order

This federal contract award, valued at $17,986.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Biktarvy 50-200-25 mg tablets, a brand-name HIV medication. This is a Firm Fixed Price delivery order contract with a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 12:13 PM